CN Patent

CN117529309A — 药物组合物及依匹哌唑口溶膜

Assigned to Jiangsu Huiju Pharmaceutical Co ltd Guangzhou Branch · Expires 2024-02-06 · 2y expired

What this patent protects

一种药物组合物及依匹哌唑口溶膜。该药物组合物包括依匹哌唑、成膜材料和增塑剂，其中所述依匹哌唑的D 90 满足：25μm≤D 90 ≤50μm。该药物组合物可以实现较好的溶出速度，改善药物含量均一性、溶出速度可控、制备工艺简单、制剂辅料简单的优点。

USPTO Abstract

一种药物组合物及依匹哌唑口溶膜。该药物组合物包括依匹哌唑、成膜材料和增塑剂，其中所述依匹哌唑的D 90 满足：25μm≤D 90 ≤50μm。该药物组合物可以实现较好的溶出速度，改善药物含量均一性、溶出速度可控、制备工艺简单、制剂辅料简单的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN117529309A
Jurisdiction
CN
Classification
—
Expires
2024-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Huiju Pharmaceutical Co ltd Guangzhou Branch
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.